Halbert's Starving Crowd: The Fertility Segments AI Still Can't Reach
AI transformed the lab side of fertility medicine. The front end still runs on 2008 tools. Here is how Halbert's Starving Crowd principle closes that gap.
The Lab Runs on AI. The Front Desk Runs on a Shared Inbox.
In 2024, a leading fertility lab published results showing AI-assisted embryo selection improved blastocyst grading consistency by over 30 percent compared to manual review. The same week that study circulated, I was reviewing a clinic's inquiry log. Forty-one leads in one week. Eleven had received a callback within 24 hours. Eleven.
That is not a technology problem. That is a prioritization problem. And it is everywhere.
The fertility industry spent the last decade modernizing everything it could see under a microscope. Preimplantation genetic testing. Time-lapse embryo imaging. AI-assisted sperm selection. The lab side of this business is genuinely extraordinary. The front end is still running on a shared Gmail account, a callback list someone printed on Tuesday, and a CRM that was last updated when Obama was in his first term.
The result is that clinics are acquiring expensive leads, often at $180 to $400 per inquiry on paid channels, and losing them in the first four hours. Not to competitors with better science. To competitors who called back first.
Framework 40 in the 47-framework system I built over 15 years inside this industry is called Halbert's Starving Crowd. Gary Halbert said it plainly: if you could have any single advantage in business, he would take a starving crowd over everything else. Great copy, beautiful branding, a perfect product, none of it matters if the audience does not desperately want what you have. Find the hungriest crowd first. Everything else is secondary.
In fertility, the starving crowd is not "women thinking about having children someday." It is three specific, identifiable segments. And every one of them is being underserved by clinics running 2008 front-end systems on 2024 ad spend.
The Three Starving Crowds in Fertility
Women 35 to 42 With Low AMH
AMH, antimüllerian hormone, is the most emotionally loaded number in reproductive medicine. It is a planning tool, not a verdict. A lower result predicts how the ovaries may respond to stimulation medications. It does not reliably predict natural fertility, and it does not close the door on IVF success. Those are clinical facts.
But patients do not receive those facts with clinical detachment. They receive them on a Tuesday afternoon, often over a patient portal message, often without adequate context. They type "low AMH 38 years old" into Google at 9:00 that night and find themselves on your landing page.
This is the starving crowd. She is not browsing. She is not comparison shopping the way someone chooses a gym membership. She has a number in her head and a timeline she did not choose. She needs a clinic that speaks directly to her reality, that acknowledges the science without catastrophizing it, and that responds to her inquiry before the anxiety peaks and she moves to the next result.
ASRM guidelines are clear: women 35 and older warrant evaluation after six months of attempting conception, not twelve. Women over 40 warrant immediate evaluation. The clinical urgency is real. The marketing urgency should match it. Framework 35, age-specific messaging, makes the same point from the copy side. Under 35, the message is proactive and empowering. At 38 to 40, the message shifts to immediate action with social proof from that specific age group. Generic clinic copy that says "we help everyone build a family" does not reach this patient. It does not even land.
Couples After a Failed IVF Cycle
A failed cycle is one of the most disorienting experiences in fertility care. The couple followed every instruction. They showed up. They did everything right. And it did not work.
What they need next is not a brochure. It is a framework for understanding what happened and what changes in the next attempt. What they want is a provider who treats their history as an asset, not a liability. A clinic that says, implicitly or explicitly, "your previous cycle tells us something useful" is speaking directly to this crowd.
This segment also converts differently. They are past the awareness stage. They are not asking whether IVF is right for them. They are asking whether your clinic is right for them, now, after they have already been through the process once. Framework 36, meta budget by awareness stage, recognizes this. Thirty percent of budget belongs in the consideration phase, meeting patients who are actively evaluating. Failed-cycle patients are deep in that phase. Marketing to them at the awareness level, explaining what IVF is, is a category error that wastes spend and loses patients.
Women After Miscarriage
Recurrent pregnancy loss affects roughly one to two percent of couples attempting conception. A single miscarriage is more common than most patients realize, occurring in an estimated 10 to 20 percent of known pregnancies. What both groups share is a sense of forward motion that stopped without explanation.
ASRM guidelines identify recurrent pregnancy loss as a condition warranting immediate evaluation, with no waiting period. The clinical need is unambiguous. The emotional need is equally urgent. Halbert's insight applies here with particular force: this is not a crowd that needs to be convinced that fertility care matters. They already know. They have already paid the emotional cost of trying. The only question is whether your clinic shows up with the right message, in the right channel, at the right time.
Cialdini's work on reciprocity and Kahneman's research on loss aversion both point to the same thing: this patient is primed to act. What stops her is not motivation. It is friction. A four-hour response time. A contact form with no confirmation. A phone that rings to voicemail at 7:00 p.m. The front-end failure is not a marketing problem. It is an operational one. And it is costing clinics the patients who were already ready to book.
Why AI in the Lab Does Not Help the Front End
The clinical technology improvements in fertility over the last decade are real and significant. Embryo vitrification survival rates above 90 percent. PGT-A reducing chromosomal abnormality transfer rates. AI-assisted morphokinetic scoring giving embryologists consistent grading at scale. This is legitimate progress.
None of it matters to the patient sitting in the inquiry queue at 9:14 p.m.
The front end of a fertility clinic in 2025 typically looks like this. Inquiries arrive from multiple channels: web forms, paid ads, referral calls, social DMs, sometimes text messages sent directly to a clinic number. These land in different places. Someone checks them in the morning. Callbacks go on a list. The list gets worked when staff have time. The CRM, if there is one, was not built for this workflow. It stores patients. It does not acquire them.
The gap between lab-side AI and front-end operations is not a gap in investment. Clinics spend real money on ads. They spend real money on clinical technology. The gap is in the assumption that the marketing system ends at the inquiry. It does not. The inquiry is where the conversion system begins.
Hopkins documented this in a different industry a century ago: the sale is made or lost in the follow-through. Ogilvy built direct response campaigns around the assumption that every word after the headline had to earn its place by moving the reader closer to action. Neither of them would recognize a fertility clinic's shared inbox as a conversion system.
Matching the Message to the Crowd
Halbert's principle is not just about identifying the right audience. It is about aligning every element of the marketing system to serve that audience's specific hunger. For the three fertility segments above, that alignment has specific implications.
Channel Timing
Framework 36 allocates meta budget across awareness, consideration, decision, and retargeting. Failed-cycle patients and post-miscarriage patients are rarely in the awareness stage. They need consideration-phase content, clinician-led explanations of what comes next, success stories from patients in the same situation, and clear scheduling CTAs. Spending awareness budget on a crowd that already understands what IVF is produces impressions. It does not produce consultations.
Retargeting Cadence
Framework 37 addresses retargeting copy specifically. The post-failed-cycle patient who visited your site and did not book is not uninterested. She is processing. A retargeting sequence that leads with gentle acknowledgment rather than promotional pressure, "Still thinking it over? That is okay. We saved your spot," converts differently than a discount offer. The message matches the emotional state of the crowd.
Ad Policy Constraints
Framework 38 on Google healthcare ad policy is the guardrail that shapes how this targeting operates within compliance. Fertility clinics can advertise fertility services, use verifiable success rates, and include scheduling CTAs. They cannot guarantee outcomes, use terms like "cure infertility," or target directly by health condition. That means the starving crowd must be reached through intent signals, search behavior, content engagement, and lookalike modeling, not by directly targeting "women with low AMH." The constraint is real. Working within it requires precision in keyword architecture and audience structure that most clinics are not currently applying.
The Bottom Line
Gary Halbert's most durable insight was that marketing skill is worth far less than market selection. Find the crowd with the most desperate need and serve them with the right message, in the right sequence, with a system that responds at the moment they are ready to act.
In fertility, that crowd exists in three segments: women 35 to 42 facing diminished ovarian reserve, couples after a failed cycle, and women navigating life after miscarriage. All three are reachable. All three are underserved. And all three are losing patience with clinics whose front-end operations cannot match the speed at which they are ready to make a decision.
The lab side of fertility medicine modernized. The front end did not. That is the gap. And it is not closed by better ads. It is closed by a system that identifies which crowd is hungriest, reaches them with the right message, and responds before the window closes.
Your CRM stores patients. It does not acquire them.
About Cima Growth Solutions and GrowthOS
The three segments above are not abstract. They are identifiable by behavior, traceable in your inquiry data, and reachable with the right sequence. What prevents most clinics from acting on them is not strategy. It is execution infrastructure.
GrowthOS, Cima's AI-powered patient engagement and marketing automation platform, is built specifically for fertility, aesthetics, regenerative medicine, and wellness clinics. It closes the front-end gap: multi-channel inquiry capture, AI-driven response sequencing, and segment-aware follow-up that matches message to audience and delivers it in the first minutes, not the first hours.
The starving crowd is out there. The question is whether your system is fast enough to reach them before someone else does.
Learn more at cimagrowth.com.
About This Framework
This is one of 47 direct response marketing frameworks Brandon Hensinger documented over 15 years inside the fertility industry, battle-tested across 100+ clinics. He is teaching all 47 publicly.
Get the complete 47 Frameworks ebook free: cimagrowth.com/47-frameworks
See how Cima Growth Solutions closes the front-end gap for specialty clinics with GrowthOS: cimagrowth.com
Read more
November 16, 2026
Quality Score and Ad Alignment: Why Fertility Clinics Pay More to Rank Lower
ReadNovember 15, 2026
Google Healthcare Ad Policy: The Fertility Clinic Rules That Determine Your Growth Ceiling
ReadNovember 14, 2026
